We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The ABPI’s Dr Richard Torbett, speaking to the International Trade Committee, said the COVID-19 pandemic highlights the need for a globalised drug supply chain.
A key element of the U.S. Food and Drug Administration's (FDA) mission is focused on helping to ensure that all products we regulate, including drugs available to consumers, are safe and of high quality.